ESTEVE CDMO, a global CDMO specializing in high-quality small-molecule APIs and pharmaceutical intermediates, began a $15.5 million expansion to enhance production capabilities and associated space at its newly acquired North American facility in Morton Grove, IL. Scheduled for completion in 2026, the investment includes reactor upgrades to add powder transfer systems, and distillation tanks. Jacket insulation and a single thermal fluid circuit will be added to enhance thermal management and ...